Huan Wang

Efficacy and safety of sintilimab in combination with chemotherapy in previously untreated advanced or metastatic nonsquamous or squamous NSCLC: two cohorts of an open-label, phase 1b study

Yingying Yu, L. Teng, N. Xu, 2020, Cancer Immunology, Immunotherapy.

Assessment of TMB, PD-L1, and lymphocyte to monocyte ratio as predictive potential in a phase Ib study of sintilimab in patients with advanced solid tumors.

B. Peng, L. Teng, N. Xu, 2021, American journal of cancer research.

Impact of a Low Preoperative Body Mass Index on the Postoperative Complications and Overall Survival of Gastric Cancer Patients: a Systematic Review and Meta-analysis

N. Xu, Huan Wang, Jing Deng, 2019, journal of nutritional oncology.

A case report of a dramatic response to olaparib in a patient with metastatic pancreatic cancer harboring a germline BRCA2 mutation

N. Xu, Yulong Zheng, C. Mao, 2019, Medicine.

Exome Sequencing and Linkage Analysis Identified Tenascin-C (TNC) as a Novel Causative Gene in Nonsyndromic Hearing Loss

Ling Yang, Xin Jin, L. Lan, 2013, PloS one.

Prognostic Value of Neutrophil–Lymphocyte Ratio, Platelet–Lymphocyte Ratio, and Combined Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Stage IV Advanced Gastric Cancer

Yongfeng Ding, Haiyong Wang, N. Xu, 2020, Frontiers in Oncology.

Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial

L. Shen, B. Peng, L. Teng, 2020, BMC Cancer.